- Home
- PCVX vs VSEC Comparison
PCVX vs VSEC Comparison
Compare PCVX & VSEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PCVX | VSEC |
|---|---|---|
| Founded | 2013 | 1959 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0B | 6.8B |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | PCVX | VSEC |
|---|---|---|
| Price | $59.23 | $194.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $88.25 | ★ $226.29 |
| AVG Volume (30 Days) | ★ 927.4K | 272.1K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.25% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.94 |
| Revenue | N/A | ★ $760,113,000.00 |
| Revenue This Year | N/A | $32.16 |
| Revenue Next Year | N/A | $21.36 |
| P/E Ratio | ★ N/A | $102.01 |
| Revenue Growth | N/A | ★ 9.88 |
| 52 Week Low | $30.81 | $154.74 |
| 52 Week High | $65.00 | $247.85 |
Technical Indicators
Market Signals| Indicator | PCVX | VSEC |
|---|---|---|
| Relative Strength Index (RSI) | 47.74 | 38.23 |
| Support Level | $58.51 | $185.88 |
| Resistance Level | $63.39 | $229.50 |
| Average True Range (ATR) | 2.10 | 8.44 |
| MACD | -0.39 | -3.02 |
| Stochastic Oscillator | 10.69 | 7.28 |
Price Performance
Historical ComparisonAbout PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.
About VSEC VSE Corporation
VSE Corp is a diversified aftermarket products and services company serving commercial and government markets. The Company's operations include aircraft and airframe parts supply and distribution, and MRO services of aircraft components and engine accessories. The Company operates as a single reportable segment: Aviation, which is a provider of aftermarket parts distribution and MRO services for components and engine accessories supporting commercial, business, and general aviation operators.